SR 12813
CAS: 126411-39-0
Ref. 3D-BFA41139
| 1g | Discontinued | ||
| 2mg | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued | ||
| 250mg | Discontinued | ||
| 500mg | Discontinued |
Product Information
Name:
SR 12813
Synonyms:
- Gw 485801
- P,P,P′,P′-Tetraethyl P,P′-[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]ethenylidene]bis[phosphonate]
- Phosphonic acid, P,P'-[2-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]ethenylidene]bis-, tetraethyl ester
- Phosphonic acid, P,P′-[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]ethenylidene]bis-, P,P,P′,P′-tetraethyl ester
- Phosphonic acid, [[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]ethenylidene]bis-, tetraethyl ester
- Sr 12813
- Tetraethyl [2-(3,5-di-tert-butyl-4-hydroxyphenyl)ethene-1,1-diyl]bis(phosphonate)
Description:
SR 12813 is a drug that inhibits the activity of p-glycoprotein (P-gp) and other drug transporters. It has been shown to inhibit the expression of P-gp in hepatocyte-like cells, which makes it a potential therapeutic agent for cancer patients with bowel diseases. SR 12813 also has a high affinity for polymerase chain reaction (PCR) amplification and shows synergistic effects with taxol in mouse monoclonal antibody models. The molecular mechanism of SR 12813 is not yet known, but it may be an ubiquitin ligase or a toll-like receptor inhibitor.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
504.53 g/mol
Formula:
C24H42O7P2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
